News | August 03, 2023
Supriya Lifescience collaborates with Plasma Nutrition for protein technology
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
Norgestrel and Ethinyl Estradiol Tablets USP (RLD Lo/Ovral-28) had an estimated annual sale of USD 34 million in the U.S. (IQVIA MAT Mar 2023)
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Aurobindo will respond to the US FDA within the stipulated timelines
This product would be manufactured at Lupin's Nagpur facility in India
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
Subscribe To Our Newsletter & Stay Updated
